Drugmakers prepare to sue EU over tax to pay for waste water clean-up - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
污染

Drugmakers prepare to sue EU over tax to pay for waste water clean-up

Pharma and cosmetics industries want other sectors to contribute ‘fair share’ towards cost of removing pollutants

Drugmakers are preparing to sue the EU over a new tax to pay to clean up polluted waste water, arguing other industries should also have to foot the bill.

The new rule, which came into force at the start of the year, requires the pharmaceutical and cosmetics industries to pay at least 80 per cent of the cost of removing pollutants such as microplastics and chemicals from urban waste water.

The European Commission has estimated the cost at about €1.2bn a year, but the German environment agency suggested it could cost up to €1.25bn to improve wastewater treatment in Germany alone.

The directive targets household waste water that has been polluted by medicines excreted in urine or by washed-off cosmetics, rather than factory waste water. It aims to protect health and the environment from the effects of such micropollutants, directing towns and cities across the bloc to remove them using an advanced process known as “quaternary treatment”. 

But the pharma industry lobby group is preparing a lawsuit that will argue that the directive breaks EU treaties on proportionality, non-discrimination and the principle of “polluter pays”, given other industries also contribute to pollutants in the water. 

The list of micropollutants the EU is targeting also includes plastics, pesticides, artificial sweeteners and illegal drugs. 

Nathalie Moll, director-general of the European Federation of Pharmaceutical Industries and Associations, said the organisation did not know why the EU has decided to target two sectors when others also contributed to the problem. 

“We are looking for a fair share of the costs being paid by all the polluting industries,” she said, adding this would not only share the financial burden, but create incentives for everyone to produce more sustainable products. 

“Our industry supports the ambition of the legislation and is 100 per cent committed to paying its fair share,” she added. 

The European Commission said: “Cosmetic and pharmaceutical residues represent the main sources of persistent micropollutants, mainly stemming from households, found in urban wastewater. Without the residues of these two sectors, there would not be a need for additional, quaternary treatment in urban wastewater facilities.”

It added that the system was “proportionate” and that it expects exemptions for smaller and medium companies with only limited sales in Europe or products that do not pollute.

The updated directive comes as drugmakers push back against EU measures that could reduce the length of drug patents, as part of a major overhaul of industry regulation. They are also increasingly worried about the risk of tariffs on imports into the US, the industry’s largest and most profitable market. 

Several EU member states, including Bulgaria and the Czech Republic, have written to the Council of the European Union to express concern about the impact of the new waste water rule on drug prices, in case the industry passes on the costs to consumers and healthcare systems. 

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

通货膨胀让美国人放弃“大豪宅”梦

即使在得克萨斯州,由于负担能力危机,拥有住房的美国梦也在缩小。

FT社评:特朗普对东南亚征收关税可能弄巧成拙

如果美国更强硬地逼迫东南亚国家在美国和中国之间做出选择,可能反而将它们推向中国的怀抱。

Lex专栏:交易所可在市场巨震中提供避风港

高波动性将提振交易并扩大价差,从而可能吸引更多交易者。

企业能否利用特朗普关税的差异?

根据“原产地规则”,转移产品供应链的部分环节可能节省大量关税支出,但试图利用这一点也伴随着风险。

“市场的一次再平衡”:福克斯新闻如何报道特朗普的贸易战

作为美国保守派人士的首选新闻来源,福克斯新闻的主持人似乎在很大程度上淡化了特朗普关税造成的冲击。

美国关税威胁到全球企业近2万亿美元的投资承诺

供应链易受全面关税影响的企业一直希望通过谈判获得华盛顿方面的让步。
设置字号×
最小
较小
默认
较大
最大
分享×